Physician profile
Karen Todd
NPI 1669427647
$3,833.40
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $939 · 2020: $729 · 2021: $749 · 2022: $800 · 2023: $616.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $616.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $837.49 | 2022-2023 | Durysta, Lumigan, Alphagan P |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $602.11 | 2019-2021 | |
| Allergan, INC. | $555.32 | 2019-2021 | |
| Merz North America, INC. | $364.06 | 2019 | |
| Sun Pharmaceutical Industries INC. | $334.44 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $322.76 | 2019-2023 | |
| Aerie Pharmaceuticals, INC. | $174.74 | 2019-2021 | |
| Oyster Point Pharma, INC. | $156.34 | 2022-2023 | Tyrvaya |
| Alcon Vision LLC | $141.87 | 2021-2023 | Rhopressa |
| Bausch & Lomb Americas INC. | $114.52 | 2022-2023 | Vyzulta |
| Horizon Therapeutics Plc | $61.00 | 2021-2023 | Tepezza |
| Rayner Intraocular Lenses Limited | $34.96 | 2022 | |
| Merz Pharmaceuticals, LLC | $29.95 | 2021 | |
| Shire North American Group INC | $23.56 | 2019 | |
| Kala Pharmaceuticals, INC. | $22.21 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $19.44 | 2023 | Callisto Eye |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Sight Sciences, INC. | $19.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Todd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.